血清PLA2R抗体及THSD7A抗体对特发性膜性肾病的临床意义

摘要

近年来,随着我国特发性膜性肾病(IMN)的发病率迅速增长,对IMN的准确诊断显的尤为重要.既往对MN患者的诊断依赖于肾穿刺活检,其虽为诊断金标准,但也是高风险的创伤性检查手段.而血清学PLA2R抗体和THSD7A抗体检测来辅助诊断特发性膜性肾病,不仅具有快速、灵敏、简便、无创的优点,而且可以实时定量反映免疫状态,与传统依据蛋白尿严重程度来判定疗效相比,其更能有效敏捷地监测病情,反映疗效和预后情况,应大力推广.%In recent years, the diagnosis of idiopathic membranous nephropathy (IMN) has been more and more important with the rapid growth rate on incidence in China.Previous diagnosis of IMN depends on renal biopsy, a gold standard, but a high risk of traumatic examination.The detection of serum PLA2R antibody and THSD7A antibody to assist in the diagnosis of is not only fast, sensitive, simple and noninvasive, but also can reflect the immune status in real time.Compared with the traditional proteinuria severity based therapeutic efficacy evaluation, that is more effective and agile to monitor the disease condition, reflect the treatment effects and predict the prognosis better.Therefore, it should be vigorously promoted.